Nomura (NMR) Insider Yukiko Ozaki Buys $71 of Stock

Yukiko Ozaki, who serves as both the Chief Human Resources Officer and Chief Health Officer at NMR, made an insider purchase of the company's stock. On June 25, 2026, Ozaki bought 8 shares at an average price of $8.86 each, totaling $70.88. This transaction was not part of a prearranged trading plan.

Other Institutional Activity in NMR

Several institutional investors made adjustments to their holdings in NMR. Donald Smith & Co., Inc. increased its stake by 473,959 shares, ending with 13,169,493 shares valued at approximately $103.9 million. Fisher Asset Management, LLC reduced its holdings by 59,894 shares to a total of 13,091,620 shares worth about $103.3 million. Morgan Stanley added 762,095 shares, bringing its total to 10,577,455 shares valued at $83.5 million. Goldman Sachs Group Inc. and BlackRock, Inc. also boosted their positions by 310,497 and 635,935 shares, respectively. FMR LLC made a significant increase, adding 1,965,300 shares, resulting in a 73.8% increase to 4,629,709 shares worth approximately $36.5 million.

Nomura Holdings, Inc. Stock Down 12.8%

Shares of NMR traded near $8.79 on Monday. The company's stock has seen fluctuating interest from institutional investors, as indicated by recent filings. The stock's performance and insider activities are closely monitored by investors looking for potential trends and insights.

Insider Buying and Selling at Nomura Holdings, Inc.

On June 25, 2026, several insiders at NMR engaged in stock purchases. Masahiro Ishizuka acquired 205 shares, while Akihito Tobari, Head of Wealth Management, bought 71 shares. Akio Hori, the Chief Information Officer, also purchased 71 shares. Hiroyasu Koike, Head of Investment Management, acquired 274 shares, and Shoji Ogawa bought 204 shares. All transactions were executed at a price of $8.86 per share.

Bottom Line

Yukiko Ozaki's recent purchase of NMR shares highlights the ongoing insider activity within the company. Investors often watch such moves for potential insights into the company's future. The recent institutional activity provides additional context for understanding the market's perception of NMR. As always, it's important to remember that these filings reflect past actions and may not indicate current positions.